NextPoint Therapeutics, Inc – Company Profile

NextPoint Therapeutics is a clinical-stage biotechnology company pioneering precision immuno-oncology through its work on the novel B7-H7/HHLA2 checkpoint axis. Its pipeline targets cancer patients who do not respond to existing PD-1/PD-L1 inhibitors, advancing first-in-class therapies including a T-cell engager, an antibody-drug conjugate with proprietary linker technology, and a multi-functional checkpoint inhibitor. NextPoint integrates foundational science from its co-founders with a defined clinical biomarker strategy, working with leading academic institutions and clinical partners worldwide to deliver new treatment options to patients with HHLA2-expressing solid tumors.

Company Headquarters: Cambridge, Massachusetts, USA
No of employees: 43+
Address: 238 Main Street, Cambridge, MA 02142, USA
Industry: Biotechnology, Immuno-Oncology
Website: https://nextpointtx.com/
Ticker Symbol & Exchange: Private (Series B-funded)
Founded: 2020
LinkedIn Profile: https://www.linkedin.com/company/nextpoint-therapeutics

* Data accurate as of 6/5/2025

Pfizer Industry Data & Analytics

Access detailed insights into NextPoint Therapeutics, including clinical activity, drug development, funding, and market presence. Our data includes up-to-date information on trials, products, leadership, and strategic positioning to support business development and competitive research.

3 ONGOING CLINICAL TRIALS
Track current clinical trials sponsored or supported by NextPoint Therapeutics, including trial phase, therapeutic focus, recruitment status, and geographic reach.

32+ PEOPLE
Review NextPoint Therapeutics' employees, roles and linkedin profiles.

This section lists key individuals across NextPoint Therapeutics, including their job roles, location, LinkedIn profiles and contact information where available. We also include links to to our AI message tool to make outreach easier than ever. Reveal the full list of people by signing up for a free trial of the SciLeads platform today!

This section lists clinical trials associated with NextPoint Therapeutics, including NCT ID, clincial trial titles, associated dates, status, phase and lead sponsor status. Reveal the full list of clinical trials by signing up for a free trial of the SciLeads platform today!

This section provides information on NextPoint Therapeutics funding history and ownership details, including venture capital involvement, funding rounds, key investors, and transaction names where available. Reveal the full funding and ownership data by signing up for a free trial of the SciLeads platform today!